Invitation to media, investor and analyst call for Medicover Q1 report 2018

Medicover’s (MCOV B) interim report for January-March 2018 will be published on 26 April at 08:00 CET.

The Company will hold a conference call (in English) for media, financial analysts and investors on 26 April at 09:30 CET.

CEO Fredrik Rågmark and CFO Joe Ryan will present the report and take questions.

Shortly before the webcast presentation slides will be available on our website.

To join the conference call please dial-in using the following details at least 10 minutes before the start of the call:

Sweden: +46 (0)8 5033 6574

UK: +44 (0)330 336 9105

Germany: +49 (0)69 2222 13420

Code: 8795826

A live audio webcast of the conference call will be available at:

For further information, please contact:

Paula Treutiger, Corporate Communication & IR Director

Phone: +46 733 66 6599 Mail:

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenues around €580 million and 15,900 employees. For more information, go to

About Us

Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.


Documents & Links